Refine Search

  •  
  •  
Biotech firm forges ahead

NEW YORK -- The tiny biotech firm EntreMed will press ahead with an experimental...analyst with OrbiMed Advisors. Shares of EntreMed lost nearly half their value Wednesday...and the stock soared as high as $85. EntreMed officials say they can survive without...

http://chronicle.augusta.com/stories/1999/02/11/bus_252962.shtml
Business
'Cancer Wars' author stresses prevention over cure

...endostatin, drugs found to eradicate tumors in mice without side effects. Excitement over the news catapulted the stock price of EntreMed, the Maryland biotech company that makes and markets them. That's OK with Robert Proctor, a history of science professor...

http://chronicle.augusta.com/stories/1998/05/26/ent_229538.shtml
Things to Do
Designing medicine

...cancer and other ailments, much like EntreMed and Genetech Inc., which have grabbed...Pharmacogenetic's drug design technology is EntreMed, the Maryland-based company whose...technology is revolutionary, according to EntreMed board member Samuel R. Dunlap, who...

http://chronicle.augusta.com/stories/1998/05/10/bus_227807.shtml
Business
Chemical that suggests prostate cancer may be fighting disease

...vessels associated with cancer progression," the team from EntreMed Inc. of Rockville, Md., reports in the Oct. 6 issue of...blood vessels to bring the tumor oxygen and nutrients. The EntreMed scientists have been working on endostatin, a protein that...

http://chronicle.augusta.com/stories/1999/10/06/tec_271956.shtml
XXX Technology
Investors gripe about trading over Internet

...placed a market order online in May to buy 1,000 shares of EntreMed, a biomedical company whose stock has been moving sharply...would be executed promptly near $13 a share, which was where EntreMed was quoted at the time. Market orders are executed fully and...

http://chronicle.augusta.com/stories/1999/01/31/bus_251854.shtml
Business
Compounds combine to kill cancer tumors

...working with the companies involved in producing the drugs -- Entremed Inc. and Bristol-Myers Squibb Co. -- to make sure there...clinical trials possibly beginning next year. The news caused Entremed's stock price to nearly quadruple Monday. The drugs, however...

http://chronicle.augusta.com/stories/1998/05/05/tec_227512.shtml
XXX Technology
Company buys rights to process

...outright, it hopes to license the process to big drug companies or to form more partnerships similar to the one it has with EntreMed Inc., the Maryland-based creator of anti-cancer drug candidates Angiostatin and Endostatin. "The deal clears the way...

http://chronicle.augusta.com/stories/2003/02/12/bus_375378.shtml
Business
Cancer-killing drugs to be tested on humans

...the National Cancer Institute, told The New York Times. Investors are putting stock in the drugs' potential. Shares of Entremed, the Rockville, Md., company that plans to make angiostatin and endostatin, more than tripled today, jumping $31.93...

http://chronicle.augusta.com/stories/1998/05/05/tec_227503.shtml
XXX Technology
Speeding up the process

...blueprints to a major drug company. Or it would like to form a partnership similar to the one it has with Maryland drug designer EntreMed Inc., creator of anti-cancer drug candidates Angiostatin and Endostatin. Dr. Hendry said there is some preliminary interest...

http://chronicle.augusta.com/stories/2002/09/01/bus_350195.shtml
Business
Endostatin safety tests so far show little results

...sponsored by the National Cancer Institute in Wisconsin, the M.D. Anderson Cancer Institute in Houston and in Boston by EntreMed Inc. Leaders of the research trials say it is too early to make an official report. They have said informally, according...

http://chronicle.augusta.com/stories/2000/05/12/tec_288486.shtml
XXX Technology